See every side of every news story
Published loading...Updated

New drug ‘could boost effectiveness of chemotherapy’, developers say

  • The drug KCL-HO-1i, developed by experts at King's College London, could enhance chemotherapy effectiveness by disarming tumor protection mechanisms.
  • Early tests showed that KCL-HO-1i helped chemotherapy-resistant tumors respond to treatment in mice, leading researchers to hope for future human trials.
  • Professor James Spicer stated that current chemotherapy often fails to be effective and long-lasting, highlighting the importance of this research.
  • If successful in trials, KCL-HO-1i could reduce the need for aggressive cancer treatments, improving patient outcomes.
Insights by Ground AI
Does this summary seem wrong?

46 Articles

Evening StandardEvening Standard
+44 Reposted by 44 other sources
Center

New drug ‘could boost effectiveness of chemotherapy’, developers say

It is hoped KCL-HO-1i can be trialled on humans, with researchers suggesting it could one day be a ‘valuable companion drug’ to chemotherapy.

·London, United Kingdom
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 92% of the sources are Center
92% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Stv broke the news in Scotland, United Kingdom on Sunday, August 10, 2025.
Sources are mostly out of (0)

Similar News Topics